CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Advanced Oncotherapy PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Advanced Oncotherapy PLC
Third Fl, 4 Tenterden Street
Phone: +44 2036178728p:+44 2036178728 LONDON, W1S 1TE  United Kingdom
Placed into Administration on 5/30/2024
On 5/30/2024, Advanced Oncotherapy PLC was placed into Administration
David Hudson and Ian James Corfield both of FRP Advisory Trading Limited were appointed as the Administrators of the Company
This company is no longer actively traded on any major stock exchange.
Business Summary
Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company’s team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202212/31/2021Yes----

Industries
SIC Code Description
3844 X-ray apparatus and tubes and related irradiation apparatus
8049 Offices and clinics of health practitioners, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Michael J.Sinclair 79 10/27/2016 6/1/2006
Chief Executive Officer, Executive Director NicolasSerandour 10/27/2016 9/1/2014
Chief Operating Officer, President, Europe EdLee 2/1/2017 2/1/2017
12 additional Officers and Directors records available in full report.

Business Names
Business Name
ADAM SA
Advanced Oncotherapy Plc
CareCapital Group Plc

General Information
Outstanding Shares: 542,573,869 (As of 6/30/2023)
Stock Exchange: LON


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024